Article
Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 15 Feb 2004
Liede Alexander, Karlan Beth Y, Narod Steven A
Abstract excerpt
Major risks conferred by BRCA1 and BRCA2 in women are for cancers of the breast, ovary, fallopian tube, and peritoneum. Male carriers of mutations in BRCA1 or BRCA2 are also susceptible to cancer; however, their risks remain poorly understood and their optimal clinical management has not yet been defined. This article reviews studies that estimate risk associated with mutations in BRCA1 or BRCA2, with a focus on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.